Innovation Exchange Amsterdam Programs & Affiliates section
Menu Close
Associated websites:

IXA

The knowledge transfer office of UvA, HvA, VU and Amsterdam UMC

Visit Website

Amsterdam Science & Innovation Award

The award for the most innovative, knowledge based idea of Amsterdam

Visit Website

Amsterdam Venture Studios

Amsterdam hub for innovative knowledge based startups

Visit Website

Demonstrator Lab

Pre-incubator, learning-by-doing, entrepreneurship laboratory

Visit Website

Entrepreneurship Cases Amsterdam

Bringing entrepreneurship education to a higher level

Visit Website

Research Facilities Amsterdam

Access to high-end research instruments, facilities and expertise

Visit Website
Home / Stories / Story of Maaike van Rest (VU Amsterdam)

Story of Maaike van Rest (VU Amsterdam)

How to make an impact with your research and what does it take to go from idea to product or service. Watch the video of Maaike van Rest. Maaike explains what has helped her to bring an idea to the market in the shape of a product.

Je cookie instellingen blokkeren deze content.
Pas je instellingen aan om de content alsnog in te laden.

Explore other Stories:

Five years of Amsterdam Venture Studios

The academic incubator facility Amsterdam Venture Studios has found its place in the heart of five campus locations in Amsterdam (Startup Village on Amsterdam Science Park, LawHub on Roeterseiland, AVS VU Campus, AVS Humanities Lab on City Centre Campus, HvA Venture Centre at the campus in Zuidoost and AVS ahti near AMC also in Zuidoost). […]

Entrepreneurship journey of VU spin-off Optics11

Talking on Dutch television about Optics11 and the collaboration with the Dutch Ministry of Defence, raising €5 million in funding for superior life science instruments and selling products worldwide: Vrije Universiteit spin-off Optics11 is scaling up. At IXA, we were curious to find out about their journey.

Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup (Amsterdam UMC)

Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential […]

All Stories